Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haim Ovadia

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Multiple Sclerosis and Related Disorders|December 14, 2019
QKI-V5 is downregulated in CNS inflammatory demyelinating diseasesIris Lavon, Ina Leykin, Hanna Charbit, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 25, 2011
Neutralization of endogenous digitalis-like compounds alters catecholamines metabolism in the brain and elicits anti-depressive behaviorInbal Goldstein, Elad Lax, Iris Gispan-Herman, et al.
Journal of Virology|July 13, 2007
Fatal neurological disease in scrapie-infected mice induced for experimental autoimmune encephalomyelitisYael Friedman-Levi, Haim Ovadia, Romana Hoftberger, et al.
Journal of Inflammation (London, England)|October 27, 2015
Nitric oxide secretion in human conjunctival fibroblasts is inhibited by alpha linolenic acidNir Erdinest, Noam Shohat, Eli Moallem, et al.
Journal of Neuroinflammation|March 23, 2012
Targeting of prion-infected lymphoid cells to the central nervous system accelerates prion infectionYael Friedman-Levi, Romana Hoftberger, Herbert Budka, et al.
Journal of Inflammation (London, England)|February 5, 2014
Expression and activation of toll-like receptor 3 and toll-like receptor 4 on human corneal epithelial and conjunctival fibroblastsNir Erdinest, Gal Aviel, Eli Moallem, et al.
Harefuah|March 22, 2013
[Inflammation of the optic nerve: when it should be considered as neuromyelitis optica--the experience of the Department of Neurology at Hadassah Hospital]Adi Vaknin-Dembinsky, Netta Levin, Noa Raz, et al.
Multiple Sclerosis and Related Disorders|April 12, 2016
T-cell responses to distinct AQP4 peptides in patients with neuromyelitis optica (NMO)Adi Vaknin-Dembinsky, Livnat Brill, Ibrahim Kassis, et al.
International Journal of Nanomedicine|December 10, 2015
Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidantOrli Binyamin, Liraz Larush, Kati Frid, et al.
Stroke|April 6, 2002
NAP, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic deathRonen R Leker, Angella Teichner, Nikolas Grigoriadis, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis and Related Disorders|December 14, 2019
QKI-V5 is downregulated in CNS inflammatory demyelinating diseasesIris Lavon, Ina Leykin, Hanna Charbit, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 25, 2011
Neutralization of endogenous digitalis-like compounds alters catecholamines metabolism in the brain and elicits anti-depressive behaviorInbal Goldstein, Elad Lax, Iris Gispan-Herman, et al.
Journal of Virology|July 13, 2007
Fatal neurological disease in scrapie-infected mice induced for experimental autoimmune encephalomyelitisYael Friedman-Levi, Haim Ovadia, Romana Hoftberger, et al.
Journal of Inflammation (London, England)|October 27, 2015
Nitric oxide secretion in human conjunctival fibroblasts is inhibited by alpha linolenic acidNir Erdinest, Noam Shohat, Eli Moallem, et al.
Journal of Neuroinflammation|March 23, 2012
Targeting of prion-infected lymphoid cells to the central nervous system accelerates prion infectionYael Friedman-Levi, Romana Hoftberger, Herbert Budka, et al.
Journal of Inflammation (London, England)|February 5, 2014
Expression and activation of toll-like receptor 3 and toll-like receptor 4 on human corneal epithelial and conjunctival fibroblastsNir Erdinest, Gal Aviel, Eli Moallem, et al.
Harefuah|March 22, 2013
[Inflammation of the optic nerve: when it should be considered as neuromyelitis optica--the experience of the Department of Neurology at Hadassah Hospital]Adi Vaknin-Dembinsky, Netta Levin, Noa Raz, et al.
Multiple Sclerosis and Related Disorders|April 12, 2016
T-cell responses to distinct AQP4 peptides in patients with neuromyelitis optica (NMO)Adi Vaknin-Dembinsky, Livnat Brill, Ibrahim Kassis, et al.
International Journal of Nanomedicine|December 10, 2015
Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidantOrli Binyamin, Liraz Larush, Kati Frid, et al.
Stroke|April 6, 2002
NAP, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic deathRonen R Leker, Angella Teichner, Nikolas Grigoriadis, et al.
Pageof 5